#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3388804	B	Inhibition of human recombinant CETP by fluorescence transfer assay	Homo sapiens	18	ALA3351249	single protein format	Scientific Literature
2.	ALA3388805	B	Inhibition of human recombinant CETP in presence of 88% human plasma by fluorescence transfer assay	Homo sapiens	1	ALA3351249	single protein format	Scientific Literature
3.	ALA3388806	A	AUC (0 to 24 hrs) in C57BL/6J mouse at 10 umol/kg, po	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
4.	ALA3388807	A	Clearance in C57BL/6J mouse at 1 umol/kg, iv	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
5.	ALA3388808	A	Mean residence time in C57BL/6J mouse at 1 umol/kg, iv	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
6.	ALA3388809	A	Volume of distribution at steady state in C57BL/6J mouse at 1 umol/kg, iv	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
7.	ALA3388810	F	Inhibition of plasma CETP activity in hemizygous human CETP transgenic mouse dosed for 5 or 14 consecutive days via oral gavage	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
8.	ALA3388811	F	Increase in HDL-cholesterol in hemizygous human CETP transgenic mouse dosed for 5 consecutive days via oral gavage	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
9.	ALA3388812	F	Increase in HDL-cholesterol in hemizygous human CETP transgenic mouse dosed for 14 consecutive days via oral gavage	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
10.	ALA3382138	F	Reduction in LDL-cholesterol in hemizygous human CETP transgenic mouse dosed for 14 consecutive days via oral gavage	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
11.	ALA3382139	F	Increase in HDL-cholesterol in hemizygous human CETP transgenic mouse at 10 mg/kg, po dosed for 5 consecutive days	Mus musculus	2	ALA3351249	organism-based format	Scientific Literature
12.	ALA3382140	F	Increase in HDL-cholesterol in hemizygous human CETP transgenic mouse at 1 mg/kg, po dosed for 5 consecutive days	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
13.	ALA3382141	F	Increase in HDL-cholesterol in hemizygous human CETP transgenic mouse at 3 mg/kg, po dosed for 5 consecutive days	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
14.	ALA3382142	A	Plasma concentration in hemizygous human CETP transgenic mouse at 10 mg/kg, po dosed for 5 consecutive days measured on day 5 and day 7 post dose	Mus musculus	2	ALA3351249	organism-based format	Scientific Literature
15.	ALA3382143	A	Plasma concentration in hemizygous human CETP transgenic mouse at 1 mg/kg, po dosed for 5 consecutive days measured on day 5 and day 7 post dose	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
16.	ALA3382144	A	Plasma concentration in hemizygous human CETP transgenic mouse at 3 mg/kg, po dosed for 5 consecutive days measured on day 5 and day 7 post dose	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
17.	ALA3382145	F	Increase in HDL-cholesterol in human CETP/human ApoB-100 transgenic mouse at 1 mg/kg, po dosed for 14 consecutive days	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
18.	ALA3382146	F	Increase in HDL-cholesterol in human CETP/human ApoB-100 transgenic mouse at 3 mg/kg, po dosed for 14 consecutive days	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
19.	ALA3382147	F	Increase in HDL-cholesterol in human CETP/human ApoB-100 transgenic mouse at 10 mg/kg, po dosed for 14 consecutive days	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature
20.	ALA3382148	F	Reduction in plasma LDL-cholesterol in human CETP/human ApoB-100 transgenic mouse at 1 mg/kg, po dosed for 14 consecutive days	Mus musculus	1	ALA3351249	organism-based format	Scientific Literature